ApaTech, a UK-based developer of orthopedic implants, has raised $45 million in a VC funding round co-led by HealthCor Partners and return backer 3i Group. The company had previously raised around $24 million, and says that it applies “the science of silicon to bone graft technology.”
ApaTech, a world leader in applying the science of silicon to bone graft technology, is delighted to announce the successful completion of a US$45 million fundraising. The proceeds of the round, led by 3i plc and new investor HealthCor Partners, are to be invested in additional commercial resources, further clinical and new product development and a significant expansion of manufacturing capacity.
CEO Simon Cartmell said “These funds allow us to continue the successful development of ApaTech into a world leading orthobiologics company. We see significant potential in Actifuse and the portfolio of new technologies we are developing and I am delighted we have been able to secure investment from, and involvement of, two world class financial institutions who clearly share our vision of the future.”
As a result of the investment the Board of Directors will change significantly. Peter Chambr